AI-generated summary
The authors retrospectively reviewed records of patients with refractory dry eye treated with intense pulsed light combined with meibomian gland expression. They report a significant decrease in SPEED2 symptom scores, with 89% of 35 analyzed patients showing a decrease, and improved meibomian gland evaluation in at least one eye in 77% of patients.
- Participants
- 35
- Who or what was studied
- Patients with refractory dry eye treated with serial IPL/MGX, with complete data from 35 of 81 consecutive charts
- Limits stated in the abstract
- The study is a retrospective analysis of medical records, and the abstract does not describe a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.